Ole Graff

679 total citations
17 papers, 353 citations indexed

About

Ole Graff is a scholar working on Dermatology, Neurology and Epidemiology. According to data from OpenAlex, Ole Graff has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Ole Graff's work include Contact Dermatitis and Allergies (5 papers), Pain Mechanisms and Treatments (3 papers) and Nail Diseases and Treatments (3 papers). Ole Graff is often cited by papers focused on Contact Dermatitis and Allergies (5 papers), Pain Mechanisms and Treatments (3 papers) and Nail Diseases and Treatments (3 papers). Ole Graff collaborates with scholars based in United States, United Kingdom and Denmark. Ole Graff's co-authors include Joseph F. Fowler, Evald Høj Christiansen, Bjarne Linde Nørgaard, Erik Simonsen, Kristian Wachtell, Jens Brock Johansen, Per Dahl Christensen, Sarah Kavanagh, Christopher F. Bell and Kristian Reich and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and American Heart Journal.

In The Last Decade

Ole Graff

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Graff United States 10 90 78 62 59 52 17 353
Hakop Gevorkyan United States 10 80 0.9× 47 0.6× 25 0.4× 10 0.2× 39 0.8× 12 301
Uram Jin South Korea 8 55 0.6× 58 0.7× 48 0.8× 17 0.3× 12 0.2× 19 297
Takashi Nagayama Japan 10 66 0.7× 20 0.3× 16 0.3× 29 0.5× 22 0.4× 29 397
Monan Angela Zhang Canada 6 39 0.4× 57 0.7× 28 0.5× 8 0.1× 161 3.1× 6 397
Yu Xue China 10 21 0.2× 67 0.9× 34 0.5× 6 0.1× 17 0.3× 28 246
Takahisa Deguchi Japan 10 48 0.5× 77 1.0× 60 1.0× 7 0.1× 28 0.5× 25 295
Anne Marshall United Kingdom 7 35 0.4× 96 1.2× 39 0.6× 45 0.8× 12 0.2× 13 279
Sang-Gon Lee South Korea 9 78 0.9× 37 0.5× 72 1.2× 7 0.1× 10 0.2× 22 281
Helen Lunde Sweden 7 111 1.2× 91 1.2× 15 0.2× 7 0.1× 11 0.2× 11 323
Jacqueline Miller United States 6 21 0.2× 51 0.7× 16 0.3× 8 0.1× 94 1.8× 9 271

Countries citing papers authored by Ole Graff

Since Specialization
Citations

This map shows the geographic impact of Ole Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Graff more than expected).

Fields of papers citing papers by Ole Graff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Graff. The network helps show where Ole Graff may publish in the future.

Co-authorship network of co-authors of Ole Graff

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Graff. A scholar is included among the top collaborators of Ole Graff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Graff. Ole Graff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Deli, Hana Florian, Weining Robieson, et al.. (2025). Using AI‐generated digital twins to boost clinical trial efficiency in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(4). e70181–e70181.
2.
3.
Zhou, Xuan, Ole Graff, & Chao Chen. (2020). Quantifying the probability of pharmacological success to inform compound progression decisions. PLoS ONE. 15(10). e0240234–e0240234. 4 indexed citations
4.
Hauber, Brett, et al.. (2016). Benefit-risk tradeoff preferences for chronic hand eczema treatments. Journal of Dermatological Treatment. 28(1). 40–46. 5 indexed citations
5.
Reich, Kristian, et al.. (2016). Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study. British Journal of Dermatology. 174(6). 1277–1281. 22 indexed citations
6.
Fong, Regan, et al.. (2015). Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance. Journal of Dermatological Treatment. 27(1). 54–58. 12 indexed citations
7.
Goméni, Roberto, et al.. (2015). Use of Longitudinal Dose–Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE). CPT Pharmacometrics & Systems Pharmacology. 4(4). 255–262. 5 indexed citations
8.
Fowler, Joseph F., et al.. (2014). A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.. PubMed. 13(10). 1198–204. 29 indexed citations
9.
Grove, Richard, S. D. Shackelford, Sieghart Sopper, et al.. (2013). Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis. European Journal of Neurology. 20(7). 1032–1042. 8 indexed citations
10.
11.
Harden, R. Norman, Roy Freeman, Michelle Rainka, et al.. (2013). A Phase 2a, Randomized, Crossover Trial of Gabapentin Enacarbil for the Treatment of Postherpetic Neuralgia in Gabapentin Inadequate Responders. Pain Medicine. 14(12). 1918–1932. 7 indexed citations
12.
Miller, David H., Thomas Weber, Richard Grove, et al.. (2012). Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet Neurology. 11(2). 131–139. 52 indexed citations
13.
Rauck, Richard, Sherwyn Schwartz, Ole Graff, et al.. (2012). A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy. Pain Practice. 13(6). 485–496. 44 indexed citations
14.
15.
Wilens, Timothy E., Thorsten Klint, Lenard A. Adler, et al.. (2008). A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Behavioral and Brain Functions. 4(1). 24–24. 20 indexed citations
16.
Tendera, Michał, Piotr Kułakowski, Józef Małolepszy, et al.. (2001). Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: A 6-month double-blind comparison with propafenone and placebo. American Heart Journal. 142(1). 93–98. 21 indexed citations
17.
Nørgaard, Bjarne Linde, Kristian Wachtell, Per Dahl Christensen, et al.. (1999). Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial. American Heart Journal. 137(6). 1062–1069. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakop Gevorkyan Breakdown of academic impact, for papers by Uram Jin Breakdown of academic impact, for papers by Takashi Nagayama Breakdown of academic impact, for papers by Monan Angela Zhang Breakdown of academic impact, for papers by Yu Xue Breakdown of academic impact, for papers by Takahisa Deguchi Breakdown of academic impact, for papers by Anne Marshall Breakdown of academic impact, for papers by Sang-Gon Lee Breakdown of academic impact, for papers by Helen Lunde Breakdown of academic impact, for papers by Jacqueline Miller
Rankless by CCL
2026